ZI
Zumiez Inc (ZUMZ)·Q4 2025 Earnings Summary
Executive Summary
- Q4 delivered improved profitability despite choppy holiday demand: net sales $279.2M (-0.9% YoY on a 13-week vs 14-week comp), gross margin up 190 bps to 36.2%, operating margin 7.2%, diluted EPS $0.78 versus ($1.73) last year (prior year included a $41.1M goodwill impairment) .
- Versus S&P Global consensus, Q4 results were essentially in-line: EPS $0.78 vs $0.785 estimate and revenue $279.2M vs $279.4M estimate; two estimates were captured for both EPS and revenue* [GetEstimates; Values retrieved from S&P Global].
- Q1 FY2025 guidance introduced: net sales $179–$183M, comps +3% to +5%, operating loss of $(16.5)–$(18.5)M, EPS loss $(0.72)–$(0.82); product margin expected down slightly to flat; management refrained from full-year guidance but expects sales and operating margin growth in FY2025 .
- Catalysts: continued gross margin expansion (private label strength, lower discounting), SG&A discipline, and a $25M buyback authorization may support sentiment; tariff exposure and a guided Q1 loss are near‑term headwinds .
What Went Well and What Went Wrong
What Went Well
- Gross margin expansion drove operating improvement: Q4 GM 36.2% (+190 bps YoY) on +160 bps product margin and +30 bps web shipping cost benefit; operating margin rose to 7.2% from a prior-year operating loss .
- Category strength: women’s was largest positive comp, followed by men’s and footwear; dollars per transaction increased, aided by higher average unit retail .
- Strategic progress: private label reached nearly 28% of FY sales (vs 23% in 2023 and 11% five years ago), with 120+ new brands launched in 2024; management emphasized staying nimble amid choppy demand .
What Went Wrong
- Holiday softness: mid‑to‑late December North America sales fell short of plan, prompting January guidance cuts for Q4 (revised to net sales $275–$277M, EPS $0.72–$0.77) .
- Inventory elevated: year‑end inventory +13.8% YoY; ~$7.4M pulled forward ahead of tariff implementation and residual holiday shortfall left levels higher than preferred .
- International headwinds: other international net sales declined 6.4% YoY in Q4; Europe’s FY comps down 4.1% despite Q4 turning positive (+3.7%) .
Financial Results
Quarterly Progression (oldest → newest)
Year-over-Year Q4 Comparison
Note: Q4 2024 included a noncash goodwill impairment charge of $41.1M related to Europe .
Actual vs Consensus (Q4 2025)
- Values retrieved from S&P Global.
Regional and KPI Breakdown (Q4 2025)
Category Highlights (Q4 2025)
Guidance Changes
Q1 FY2025 Guidance Introduced
Q4 FY2025 Guidance Progression and Outcome
Earnings Call Themes & Trends
Management Commentary
- “We delivered a substantial improvement in fourth quarter operating profitability driven by significant gross margin expansion and a meaningful reduction in operating expenses… This unexpected choppiness is indicative of the environment… Our plan for 2025 is to stay the course… while staying nimble and financially flexible to deliver enhanced profitability.” – Rick Brooks, CEO .
- “Operating profit more than doubled to $20 million and EPS increased 95% to $0.78 after adjusting prior-year numbers for the… goodwill impairment… This improvement reflects the successful execution of our strategic initiatives.” – Rick Brooks .
- “Private label… reached nearly 28% of total sales for the year, up from 23% in 2023 and compared to 11% just 5 years ago.” – Rick Brooks .
- “The 190 basis point increase in gross margin was primarily driven by 160 basis points of improvement in product margin and 30 basis points of benefit in web shipping costs.” – Chris Work, CFO .
- “We anticipate loss per share will be between a negative $0.72 and negative $0.82… For the first quarter… Comparable sales… between 3% and 5%.” – Chris Work .
Q&A Highlights
- Tariffs and sourcing: ~50% of North America receipts were from China exiting FY2024; plan to meaningfully reduce in 2025 by diversifying production; inventory was pulled forward ahead of tariffs .
- Leverage and flow-through: Management expects gross margin leverage (product margin, occupancy, distribution) and SG&A growth in line with sales; flow‑through could be “30%+” if sales exceed plan; operating margin can grow on a low-single-digit comp .
- Tone: Cautiously optimistic given macro uncertainty; focus on margin expansion and disciplined expense management .
Estimates Context
- Q4 FY2025 actual vs S&P Global consensus: EPS $0.78 vs $0.785; revenue $279.2M vs $279.4M—both essentially in-line; # of estimates = 2 for both EPS and revenue* [GetEstimates; Values retrieved from S&P Global].
- Implications: Limited estimate revision pressure for Q4; Q1 guidance for a loss likely prompts near-term estimate recalibration lower for EPS, with potential offsets if gross margin continues to improve .
Key Takeaways for Investors
- Margin story intact: Product margin and shipping efficiencies lifted GM and operating margin; management expects further margin gains in FY2025 as private label scales and discounts normalize .
- Top-line steady but choppy: Q4 comps +5.9%; Q1-to-date comps +4.3% with NA strength; calendar effects and holiday softness highlight volatility .
- Inventory/timeing: Elevated year-end inventory (part tariff pull-forward) should unwind; planning for product margin increases in FY2025 suggests confidence in mix quality .
- Strategic mix: Women’s, men’s, and footwear momentum plus 120+ new brands and rising private label penetration underpin GM durability .
- Cost discipline: SG&A leverage and store rationalization (31 closures in 2024; ~20 planned in 2025) support operating margin expansion even on low-single-digit comps .
- Capital allocation: $25M repurchase authorization adds support; balance sheet remains debt-free with $147.6M cash and marketable securities at year-end .
- Near-term trading lens: In-line Q4, cautious Q1 loss guide, and tariff narrative could cap upside near-term; sustained GM improvement and buyback are supportive on weakness .
* Values retrieved from S&P Global.
Citations: Q4 press release/8-K including financial statements ; Q4 call transcript ; Holiday sales update and guidance revision ; Q3 press release ; Q2 press release .